LUMOS PHARMA INC (LUMO) Stock Analyst Earnings Estimates
NASDAQ:LUMO - Nasdaq - US55028X1090 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 200K | 1.5M 650.00% | 2.051M 36.73% | 5.827M 184.11% | 867.204K -85.12% | 11.547M 1,231.52% | -100.00% | 10.098M | 438.18M 4,239.28% | 571.56M 30.44% | 702.4M 22.89% | |
| EBITDA YoY % growth | -31M -20.62% | -32M -3.23% | -36.57M -14.28% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -31.3M -19.01% | -32M -2.24% | -36.614M -14.42% | -37.38M -2.09% | -42.989M -15.01% | -38.398M 10.68% | -42.609M -10.97% | -39.946M 6.25% | -16.199M 59.45% | 835.38K 105.16% | 45.803M 5,382.89% | |
| Operating Margin | -15,650.00% | -2,133.33% | -1,785.18% | -641.50% | -4,957.25% | -332.54% | N/A | -395.58% | -3.70% | 0.15% | 6.52% | |
| EPS YoY % growth | -3.65 -310.11% | -3.71 -1.64% | -4.19 -12.94% | -3.83 8.71% | -2.20 42.40% | -1.33 39.81% | 7.88 694.62% | 14.28 81.11% | 15.17 6.21% | 20.56 35.57% | 25.43 23.66% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.72 38.76% | -0.88 32.00% | -0.98 -5.29% | -1.03 -14.47% | -1.12 -56.58% |
| Revenue Q2Q % growth | 385.815K -53.29% | -100.00% | -100.00% | -100.00% | -100.00% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -9.437M 5.67% | -9.617M 11.47% | -10.936M -39.80% | -12.03M -57.46% | -13.834M -46.60% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.90 13.46% | -0.78 | -0.12 | -15.49% |
| Q2 2024 Q2Q % growth | -0.93 14.68% | -1.26 | 0.33 | 26.47% |
| Q1 2024 Q2Q % growth | -1.29 -44.94% | -1.20 | -0.09 | -7.54% |
| Q4 2023 Q2Q % growth | -1.17 -18.18% | -1.17 | 0.00 | 0.26% |
| Q3 2023 Q2Q % growth | -1.04 -20.93% | -1.17 | 0.13 | 11.18% |
| Q2 2023 Q2Q % growth | -1.09 -15.96% | -1.12 | 0.03 | 2.56% |
| Q1 2023 Q2Q % growth | -0.89 3.26% | -1.15 | 0.26 | 22.32% |
| Q4 2022 Q2Q % growth | -0.99 -47.76% | -0.95 | -0.04 | -4.18% |
| Q3 2022 Q2Q % growth | -0.86 4.44% | -1.03 | 0.17 | 16.40% |
| Q2 2022 Q2Q % growth | -0.94 9.62% | -1.01 | 0.07 | 6.51% |
| Q1 2022 Q2Q % growth | -0.92 11.54% | -0.91 | -0.01 | -1.12% |
| Q4 2021 Q2Q % growth | -0.67 -116.13% | -0.94 | 0.27 | 28.47% |
| Q3 2021 Q2Q % growth | -0.90 -528.57% | -1.09 | 0.19 | 17.67% |
| Q2 2021 Q2Q % growth | -1.04 -60.00% | -1.05 | 0.01 | 1.33% |
| Q1 2021 Q2Q % growth | -1.04 -642.86% | -0.89 | -0.15 | -16.62% |
| Q4 2020 Q2Q % growth | -0.31 84.34% | -0.88 | 0.57 | 64.74% |
| Q3 2020 Q2Q % growth | 0.21 108.64% | -0.66 | 0.87 | 131.92% |
| Q2 2020 Q2Q % growth | -0.65 73.25% | -0.73 | 0.08 | 10.66% |
| Q1 2020 Q2Q % growth | -0.14 94.24% | -0.84 | 0.70 | 83.36% |
| Q4 2019 Q2Q % growth | -1.98 | -2.57 | 0.59 | 22.97% |
| Q3 2019 Q2Q % growth | -2.43 | -2.48 | 0.05 | 1.96% |
| Q2 2019 Q2Q % growth | -2.43 | -2.66 | 0.23 | 8.72% |
| Q1 2019 Q2Q % growth | -2.43 | -2.80 | 0.37 | 13.21% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 726K 10,271.43% | 206.652K | 519.348K | 251.32% |
| Q2 2024 Q2Q % growth | 488K -7.40% | 339.997K | 148.003K | 43.53% |
| Q1 2024 Q2Q % growth | 165K -76.12% | 308.652K | -143.652K | -46.54% |
| Q4 2023 Q2Q % growth | 826K 65.20% | 1.785K | 824.215K | 46,174.51% |
| Q3 2023 Q2Q % growth | 7K -98.60% | 331.908K | -324.908K | -97.89% |
| Q2 2023 Q2Q % growth | 527K 31.75% | 423.473K | 103.527K | 24.45% |
| Q1 2023 Q2Q % growth | 691K 591.00% | 189.037K | 501.963K | 265.54% |
| Q4 2022 Q2Q % growth | 500K 150.00% | 116.617K | 383.383K | 328.76% |
| Q3 2022 Q2Q % growth | 500K | 68.003K | 431.997K | 635.26% |
| Q2 2022 Q2Q % growth | 400K | 16.177K | 383.823K | 2,372.62% |
| Q3 2021 Q2Q % growth | -100.00% | % | ||
| Q4 2020 Q2Q % growth | -100.00% | 10.2K | -10.2K | -100.00% |
| Q3 2020 Q2Q % growth | 100K | 1.989M | -1.889M | -94.97% |
| Q4 2019 Q2Q % growth | 400K | 255K | 145K | 56.86% |
| Q1 2019 Q2Q % growth | 102K | -102K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -4.85% | 0.4% | -4.9% |
| Revenue | -91.21% | -94.6% | 0% | -23.84% |